Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2023-03-08

FDA Approved: ZOLPIDEM TARTRATE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for zolpidem tartrate from Sun Pharmaceutical Industries, Inc., under ANDA 204170.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Zolpidem Tartrate (zolpidem tartrate)

Snippet

SUPPL AP for ZOLPIDEM TARTRATE (ZOLPIDEM TARTRATE)